Australian Institute of Health and Welfare (2022) Diabetes: Australian facts, AIHW, Australian Government, accessed 28 November 2022.
Australian Institute of Health and Welfare. (2022). Diabetes: Australian facts. Retrieved from https://pp.aihw.gov.au/reports/diabetes/diabetes
Diabetes: Australian facts. Australian Institute of Health and Welfare, 13 July 2022, https://pp.aihw.gov.au/reports/diabetes/diabetes
Australian Institute of Health and Welfare. Diabetes: Australian facts [Internet]. Canberra: Australian Institute of Health and Welfare, 2022 [cited 2022 Nov. 28]. Available from: https://pp.aihw.gov.au/reports/diabetes/diabetes
Australian Institute of Health and Welfare (AIHW) 2022, Diabetes: Australian facts, viewed 28 November 2022, https://pp.aihw.gov.au/reports/diabetes/diabetes
Get citations as an Endnote file:
Based on the latest available measured data from the Australian Bureau of Statistics (ABS) 2011–12 Australian Health Survey (AHS), an estimated 420,000 (3.1%) people aged 18 and over were living with Impaired Fasting Glucose (IFG) (AIHW analysis of ABS 2014).
What is impaired fasting glucose?
The initial stages of type 2 diabetes, also known as pre-diabetes, are characterised by impaired glucose regulation, including both impaired fasting glucose (IFG) and impaired glucose tolerance (IGT) (WHO and IDF 2006). IFG is characterised by higher than usual levels of glucose in the blood when fasting (in the range of 6.1 to 6.9 mmol/L) but less than diabetes levels (at least 7.0 mmol/L). People who have IFG or IGT are at risk of future development of diabetes. Without intervention, approximately 1 in 3 people living with pre-diabetes will develop type 2 diabetes within 10 years (Bell et al. 2020).
Early treatment and improved management of impaired glucose regulation may help to reduce the occurrence of type 2 diabetes. Interventions such as weight reduction, healthy eating, regular physical activity and reducing sedentary behaviour, stress management and smoking cessation, psychological support and appropriate pharmacotherapy can slow the progression of IFG and IGT to diabetes (Bell et al. 2020)
In the ABS 2011–12 AHS, a person who did not currently have diabetes but had an IFG result ranging from 6.1 to 6.9 mmol/L was considered to be at high risk of diabetes. The ABS 2011–12 AHS collected measured data on IFG. IGT was not measured (ABS 2013).
The bar chart shows the proportion of adults living with impaired fasting glucose, by age and sex in 2011–12. A higher proportion of men (4.1%) than women (2.1%) were living with impaired fasting glucose.
In 2011–12, there were no statistically significant differences in the proportion of men and women living with IFG across geographic areas and socioeconomic areas (AIHW analysis of ABS 2014).
Australian Bureau of Statistics (ABS) (2013) Australian Health Survey: User’s Guide, 2011–13, Fasting plasma glucose, ABS Website, accessed 4 March 2022.
ABS (2014) Microdata: Australian Health Survey, Core Content - Risk Factors and Selected Health Conditions, 2011–12, AIHW analysis of detailed microdata, accessed 4 March 2022.
Bell K, Shaw JE, Maple-Brown L, Ferris W, Gray S, Murfet G et al. (2020) A position statement on screening and management of pre-diabetes in adults in primary care in Australia, Diabetes research and clinical practice, 1;164:108188, doi.org/10.1016/j.diabres.2020.108188.
WHO and IDF (World Health Organization and International Diabetes Federation) (2006) Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia: report of a WHO/IDF consultation, WHO, accessed 1 December 2021.
We'd love to know any feedback that you have about the AIHW website, its contents or reports.
The browser you are using to browse this website is outdated and some features may not display properly or be accessible to you. Please use a more recent browser for the best user experience.